Cubist Systematic Strategies’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-35,935
Closed -$117K 2657
2019
Q4
$117K Buy
+35,935
New +$104K ﹤0.01% 2162
2017
Q4
Sell
-49,062
Closed -$166K 2249
2017
Q3
$166K Buy
49,062
+19,144
+64% +$53.2K 0.01% 1512
2017
Q2
$74K Buy
29,918
+12,665
+73% +$29.1K ﹤0.01% 1497
2017
Q1
$39K Sell
17,253
-35,798
-67% -$79.2K ﹤0.01% 1501
2016
Q4
$112K Buy
53,051
+28,280
+114% +$78.9K 0.01% 1453
2016
Q3
$83K Sell
24,771
-7,539
-23% -$23.9K 0.01% 1510
2016
Q2
$101K Buy
32,310
+9,794
+43% +$32.7K 0.01% 1502
2016
Q1
$75K Sell
22,516
-929
-4% -$2.9K ﹤0.01% 1439
2015
Q4
$83K Buy
23,445
+2,233
+11% +$9.35K ﹤0.01% 1537
2015
Q3
$107K Buy
+21,212
New +$122K 0.01% 1618

Other funds holding PDLI